Hybrid atrial fibrillation ablation: long-term outcomes from a single-centre 10-year experience

• DOI: 10.1093/europace/euad114
• Publication Date: 2023-05-29T12:30:10Z
• Authors: Luigi Pannone; Sahar Mouram; Domenico Giovanni...; Antonio Sorgente; Cinzia Monaco; Alvise Del Monte; Anaïs Gauthey; Antonio Bisignani; Rani Kronenberger; Gaetano Paparella; Robbert Ramak; Ingrid Overeinder; Gezim Bala; Alexandre Almorad; Erwin Ströker; Juan Sieira; Pedro Brugada; Gian Battista Chi...; Mark La Meir; Carlo de Asmundis
• Keywords: Ablation Techniques; hybrid ablation; Surgical ablation; 3. Good health; Treatment Outcome; Clinical Research; Tachycardia; Atrial Fibrillation; Catheter Ablation; Thoracoscopic ablation; Humans; Heart Atria; Follow-Up Studies; Retrospective Studies

Hybrid atrial fibrillation (AF) ablation is a promising approach in non-paroxysmal AF. The aim of this study to assess the long-term outcomes hybrid large cohort patients after both an initial and as redo procedure.All consecutive undergoing AF at UZ Brussel from 2010 2020 were retrospectively evaluated. was performed one-step procedure: (i) thoracoscopic followed by (ii) endocardial mapping eventual ablation. All received PVI posterior wall isolation. Additional lesions based on clinical indication physician judgement. Primary endpoint freedom tachyarrhythmias (ATas). A total 120 included, 85 (70.8%) underwent first procedure (non-paroxysmal 100%), 20 (16.7%) second 30%), 15 (12.5%) third 33.3%). After mean follow-up 62.3 months ± 20.3, 63 (52.5%) experienced ATas recurrence. Complications occurred 12.5% patients. There no difference between vs. (P = 0.53). Left volume index recurrence during blanking period independent predictors recurrence.In ablation, survival 47.5% ≈5 years follow-up. or redo.